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Edited by Angel NebredaAbstract Tome-1, which refers to a trigger of mitotic entry 1,
mediates the destruction of the mitosis-inhibitory kinase,
Wee1, via the E3 ligase, SCF. In turn, Tome-1 itself is targeted
for degradation by APC in the G1 phase of the cell cycle. In the
present study, we analyzed the human and mouse Tome-1 pro-
moter regions. Using synchronized cultures of NIH3T3 cells
transfected with Tome-1 promoter/luciferase constructs, we
showed that the promoter activity of Tome-1 is activated at
the G2/M phase. Using various Tome-1 promoter/luciferase con-
structs, we showed that the CCAAT box located upstream of the
transcription initiation site is important for the basal promoter
activity. We identiﬁed a repressor element (cell-cycle-dependent
element/cell cycle gene homology region) in the vicinity of the
transcription start site, and mutations within this element dimin-
ished the cell-cycle-dependent transcriptional regulation of
Tome-1.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Gene transcription1. Introduction
Data accumulated over the last several years have demon-
strated that the cell cycle phase transitions are driven by waves
of ubiquitin-dependent degradation of key cell cycle regula-
tors. SCF (Skp1/Cullin/F-box protein) complexes and ana-
phase-promoting complexes (APC) represent two major
classes of ubiquitin ligases, whose activities are thought to pri-
marily regulate the G1/S and metaphase/anaphase cell cycle
transitions, respectively [1,2]. It has also become clear that cell
cycle progression requires the timely transcriptional activation
of cell cycle regulators at speciﬁc stages of the cell cycle. Re-
cently, Ayad et al. [3] reported the identiﬁcation of a novel
G1 substrate of the APC, that they termed Xenopus Tome-1,
which mediates the destruction of the mitosis-inhibitory ki-
nase, Wee1, via E3 ligase, SCF. Degradation of Tome-1 during
G1 allows for Wee1 accumulation during the interphase, there-
by providing a critical link between the APC and SCF path-Abbreviations: CDE, cell-cycle-dependent element; CHR, cell cycle
gene homology region; APC, anaphase-promoting complex; ChIP,
chromatin immunoprecipitation
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doi:10.1016/j.febslet.2005.01.055ways in the regulation of Cdk1/cyclin B activity [3]. This
synergistic destructive action by APC and SCF has important
implications for the timely entry of cells into mitosis [4,5].
To investigate the mechanisms regulating the expression of
the mammalian Tome-1 gene, we cloned the 5 0 region of the
human and mouse Tome-1 gene and analyzed their activities
by luciferase assay. Here, we show that Tome-1 expression is
transcriptionally regulated in a cell-cycle-dependent manner.
This transcriptional regulation is achieved by the bipartite
repressor element, termed cell-cycle-dependent element
(CDE)/cell cycle gene homology region (CHR). The CDE/
CHR element has been shown to be important for the cell-cy-
cle-dependent expression of cyclin A, cyclin B2, cdc25C, cdc2,
B-myb, survivin, and polo-like kinase genes [6–16]. The present
manuscript demonstrates that cell-cycle-speciﬁc transcriptional
regulation is, at least in part, responsible for the tight regula-
tion of the Tome-1 function.2. Materials and methods
2.1. Cell culture, synchronization, and DNA transfection
NIH3T3 cells were cultured in Dulbeccos modiﬁed Eagles medium
(DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS)
and penicillin/streptomycin. For transient transfections, 5 · 104 cells/
well (24 well plate) were plated 24 h prior to transfection. Cells were
then transfected with 200 ng of various luciferase gene constructs using
FuGENE6 reagent, as described by the manufacturer (Roche). After
24 h, the transfection medium was replaced with DMEM supple-
mented with 10% FBS. Luciferase assay was performed as described
previously [17]. Brieﬂy, 200 ng of ﬁreﬂy luciferase reporter plasmid
(pGL3, Promega) and 0.6 ng of Renilla luciferase reporter plasmid
(pRL-TK, Promega) per 24-well dish were used in each transfection.
The cells were harvested 48 h after transfection, and luciferase assay
was performed using the Dual-Luciferase Reporter Assay System fol-
lowing the manufacturers protocol (Promega). Experiments were done
at least in triplicate and the relative activities and S.E. values were
determined. To control for transfection eﬃciency, ﬁreﬂy luciferase val-
ues were normalized to the values for Renilla luciferase.
For cell cycle analysis, cells were cultured for 48 h in DMEM with-
out FBS. Then, the cells were harvested for 0 h time-point. The cells
were stimulated with 15% FBS in DMEM to re-enter the cell cycle
and subsequently analyzed at the indicated time-points. FACS analysis
was performed as previously described [18].2.2. RT-PCR
Total RNA was prepared using the TRIZOL reagent (Invitrogen)
according to the manufacturers instructions. The reverse transcription
reaction was carried out using SuperScript II reverse transcriptase
from Invitrogen following the recommendations of the manufacturer.
The PCR settings were as follows: 1 min at 94 C, 1 min at 60 C, and 1
min at 72 C for 28 cycles. The primer sequences for the ampliﬁcation
of mouse Tome-1 mRNA are 5 0-GTTAGAGCAAAGCTACACCG-3 0blished by Elsevier B.V. All rights reserved.
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separated through 1.2% agarose gels and visualized on an ultraviolet
transilluminator. Also quantitative RT-PCR was performed using
indicated primers with SYBR green (PE Biosystems) on the ABI Prism
7700 sequence detection system. Final reaction products were run on a
1.2% agarose gel and conﬁrmed to be a single band at the correct
molecular weight. Tome-1 mRNA were normalized to GAPDH
mRNA levels.
2.3. Tome-1 promoter construction and mutant derivatives
The human and mouse Tome-1 promoter fragments were gener-
ated by PCR from genomic DNA, ligated into the KpnI/HindIII-di-
gested pGL3-basic vector (Promega), and sequenced. PCR primers
with KpnI and HindIII sites artiﬁcially installed at the 5 0 and 3 0
ends, respectively, were used to synthesize inserts that were sub-
cloned into the pGL3-Basic vector. Ampliﬁcation of the promoter
sequences was performed using oligonucleotide primers for the hu-
man promoter, 809F (5 0-CGACGCGCGAGAATGGCAGTTG-
GACGGAGC) and 1R (5 0-CTCAACTCCCGAAGTTACC), and
for mouse promoter, 732F (5 0-AGGCAAGACGCGCGAGATCG)
and 3R (5 0-ATAACTCCCAAAGCCCGGAG), which are num-
bered relative to the transcription initiation site at +1, described in
the NCBI UniGene Database. The GenBank accession numbers of
the human and mouse genomic clone used for the designation of
the PCR primers were U47924 and AC002397, respectively. The
pGL3-69 vector was constructed with the primer, 5 0-GGC-
TCAGCCAAT(M1)AGGGTCAGGGCAGGGGGCG(M2)TGGCGG
(M3)GAAGTTTGAA(M4)ACT, where the nucleotides shown in
italics in the underlined sequences were mutated as follows: NF-Y
site, 5 0-TTCCC (M1); SP1 site, 5 0-GGAAGCG (M2); CDE site,
5 0-GGAAA (M3); and CHR site, 5 0-TTCCAA (M4).
2.4. Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as previously described [17]. Brieﬂy, a
150 cm2 dish with subconﬂuent NIH3T3 cells was used for each ChIP,
and asynchronously growing cells were treated with formaldehyde at a
ﬁnal concentration of 1% to create protein–DNA cross-links, and theA
B CDE
T T A G C G C G
G G C T G G C G
T A G T C G C G
T A G T C G C G
A A G C G A C G
C A G C G G C G
G C G T G G C G
G C G T G G A G
h  cdc2
h  cdc25C
h  cyclin A 
m cyclin A 





Fig. 1. Sequence homologies of the human and mouse Tome-1 promoter. (A
Tome-1 promoters. Numbering is relative to the transcriptional initiation site
CDEs, CHRs, and the element that has been shown to bind NF-Y transcriptio
and Tome-1 promoter sequences in the region of the CDE/CHR element. Ccross-linked chromatins were then extracted, diluted with RIPA buﬀer
(50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 0.1% sodium deoxycholate, and protease inhibitor cocktails), and
sheared by sonication on ice to an average length of 700 bp. After
being precleared with the protein A–Sepharose beads (4 C for 4 h)
and blocked with 1% bovine serum albumin, the chromatin was di-
vided into equal samples for immunoprecipitation with 2–5 lg of either
anti-NF-YA (sc-7711) (Santa Cruz Biotechnology) or anti-Flag anti-
body (Sigma). After incubation at 4 C overnight, a 15-ll aliquot of
a 50% slurry of the pre-blocked protein A–Sepharose beads was added
and the resultant immune complexes were pelleted by centrifugation
after 3 h incubation at 4 C, and washed several times with RIPA buf-
fer. The immunoprecipitates were resuspended in TE buﬀer and the
cross-links were reversed by overnight incubation at 65 C with pro-
teinase K and RNase A. Following phenol/chloroform extraction
and ethanol precipitation, the pellets were resuspended in 50 ll of dis-
tilled water and analyzed by PCR. As input control, 1/200th volume of
chromatin was ampliﬁed. PCR primers for the Tome-1 (5 0-AGCAG-
TAGTCAATGAGGCGA and 3R) and actin promoters (negative
control) were used to detect the promoter fragments in the immuno-
precipitates. The ampliﬁed products were separated on 1.2% agarose
gels and visualized under an ultraviolet transilluminator.3. Results and discussion
3.1. Structure of the human and mouse Tome-1 gene 5 0 ﬂanking
sequences
To determine characteristic transcription-factor-binding ele-
ments conserved between the human and mouse Tome-1 gene,
we searched the 5 0 ﬂanking sequence using the TRANSFAC
software (ver. 4.0, cutoﬀ 85). Fig. 1A shows the sequence align-
ment of the homologous 5 0 ﬂanking regions of the human and
mouse genes and shows a few sequences similar to those in pre-
viously identiﬁed transcription-regulatory elements. Both lackCHR
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1490 K. Yoshida / FEBS Letters 579 (2005) 1488–1492a typical TATA box, but contain a CCAAT box and a repres-
sor element termed CDE/CHR (consensus sequence: 5 0-G/
CGC/TGG/C-NNNG/A-T/CTTGAA-3 0), which is surrounded
by a GC stretch containing a putative SP1 consensus element in
a region upstream of the transcription start site. As revealed for
the other previously described CDE/CHR elements, the loca-
tion of this CDE/CHR-like sequence is also immediately up-
stream of the transcription initiation site (Fig. 1B).0
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C3.2. Induction of the Tome-1 promoter activity during G2/M
To examine the cell-cycle-dependent regulation of the hu-
man and mouse Tome-1 promoters, we cloned the 5 0 region
of the human and mouse Tome-1 gene and analyzed their
activities by luciferase assay. NIH3T3 cells were synchronized
at the G0/G1 phase by serum starvation and harvested at
various time-points after re-introduction into the cell cycle.
Flow-cytometric analysis was performed on propidium io-
dide-stained cells to determine the DNA content as a control
for synchrony. It was observed that 90% of the cells were ar-
rested by serum starvation. NIH3T3 cells entered the G1 phase
immediately after release from serum starvation, remained pre-
dominantly in the S phase for 22 h, and showed a predomi-
nance of G2/M populations at 26–30 h (Fig. 2A). In our
experiments, using the full promoter region of human and
mouse Tome-1, we observed an approximately 6–8-fold in-
crease of luciferase activity in the G2/M phase (Fig. 2B). The
time-course of changes of endogenous mouse Tome-1 mRNA
expression during the cell cycle was similar to the activity of
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Fig. 2. Tome-1 promoter confers cell-cycle-dependent transcription to
a luciferase reporter. Cells were synchronized by serum starvation for
48 h and then restimulated. The time-point after restimulation is
indicated. (A) Flow-cytometric analysis of the DNA content of the
cells at the indicated time-points (in hours) after release from the serum
starvation is shown. Quantitation of the percentage of cells in diﬀerent
stages of the cell cycle was based on the cellular DNA content. (B)
Luciferase activity from cell lysates standardized to Renilla luciferase.
Values were plotted as relative luciferase activities, with that at time 0
(human Tome-1) taken as 1. (C) Time-course of changes in the mRNA
expression. Changes in the gene expression levels were measured by
real-time RT-PCR and expressed as the magnitude of change relative
to the level at Time 0 taken as 1. The amount of mRNA detected was
extrapolated from a standard curve and the results were expressed as
the ratio of the amount of Tome-1 in total RNA to the amount of the
housekeeping gene, GAPDH, in total RNA.3.3. Identiﬁcation of the promoter fragment conferring
activation of the Tome-1 promoter
To identify the functional elements, a deletion mutant of the
fragment was examined for promoter activity. Fragments de-
leted up to nucleotide position 69 (pGL3-69) exhibited
approximately only 50% activity relative to those deleted up
to nucleotide position 809 (pGL3-809) (Fig. 3A). This result
indicates that the region between 809 and 70 is essential for
the full promoter activity of Tome-1. The critical region re-
quired for minimal expression of the Tome-1 promoter activity
was found to be located between nucleotide positions 69 and
20. This region includes a CCAAT box and a GC stretch re-
gion containing a consensus SP1 site. To identify the sequences
within this region that are responsible for the promoter activity
of Tome-1, we generated a series of mutated plasmids (Fig.
3A). To assess the activity of the CCAAT box sequences and
the GC stretch (SP1) site, we introduced substitutional muta-
tions in these sequences. CCAAT was converted to TTCCC
(pGL3-69 M1), and GGGGGCG was converted to
GGAAGCG (pGL3-69 M2). These constructs were transfec-
ted into asynchronously growing NIH3T3 cells. Mutation of
the CCAAT box resulted in a 60% reduction of the promoter
activity as compared to that of the wild-type Tome-1 promoter
construct (Fig. 3A). On the other hand, mutation of the SP1
site had no eﬀect on the promoter activity (Fig. 3A). Taking
into account the decrease of the promoter activity of pGL3-
69 M1, containing the mutated CCAAT box, it was concluded
that at least the CCAAT-box-binding factor NF-Y may be
important for positive regulation of the Tome-1 promoter.
To further assess the contribution of NF-Y on the Tome-1
promoter activity, YA13m29, a dominant-negative mutant ofNF-Y subunit A, was employed [10,19]. NF-Y is a heteromeric
protein composed of three subunits, NF-YA, NF-YB, and
NF-YC, all known to be essential for DNA binding [20,21].
The pGL3-69 reporter plasmid was co-transfected with
increasing amounts of a construct expressing YA13m29 and
assayed in normal growing cells. More than 60% of the human
Tome-1 promoter activity was lost in the case of transfection
of the highest concentration of the dominant-negative mutant
of NF-YA (Fig. 3B). To test for in vivo NF-YA binding, we
performed ChIP assay using antibody against NF-YA. The
chromatin immunoprecipitated by the antibodies was then
Fig. 3. Deletion and mutation analysis of the Tome-1-gene-regulatory sequences. (A) Diagrammatic representations of the luciferase reporter gene
constructs. Box, CDE and CHR region; oval, CCAAT box (NF-Y); X, mutation sites. A GC stretch sequence containing the SP1 site is indicated.
The M1 mutation is TTCCC from the original sequence CCAAT. NIH3T3 cells were transfected with 200 ng of a reporter construct together with 0.6
ng of pRL-TK, as described under Section 2. At 48 h after transfection, the cells were harvested, and extracts were prepared to measure the ﬁreﬂy and
Renilla luciferase activities. Values are represented as relative luciferase activities (%), with that of pGL3-809 taken as 100. (B) NIH3T3 cells were
transfected with constant amounts of the wild-type pGL3-69 reporter plasmid, Renilla-luciferase-expressing internal control plasmid, and increasing
quantities of a plasmid coding for a dominant-negative mutant of transcription factor NF-Y subunit A, YA13m29. Total DNA amounts in the
transfections were kept constant. Values are represented as relative luciferase activities (%), with that of pGL3-69 taken as 100. (C) Direct association
of NF-Y with the promoter of Tome-1. ChIP assay was performed using no antibody, an irrelevant antibody (anti-Flag), and antibodies against NF-
YA. PCR primers for the Tome-1 and actin promoters (negative control) were used to detect the promoter fragments in the immunoprecipitates. The
input lane represents 0.5% of the total chromatin used in the ChIP assays. (D) Eﬀect of mutations within the CDE and CHR elements on the
promoter activity. The M3 and M4 mutations GGAAA and TTCCAA were made from the original sequence GGCGG and TTTGAA, respectively.
Wild-type (pGL3-69) and mutant constructs (pGL3-69 M3 and pGL3-69 M4) were transfected into NIH3T3 cells; 18 h after transfection, the cells
were serum-starved for 48 h to cause cell cycle arrest at the G0/G1 phase and serum was then re-added for the indicated period to re-introduce the
cells into the cell cycle. The relative luciferase activity of G2/M versus G1 cells is given for the wild-type and mutant constructs.
K. Yoshida / FEBS Letters 579 (2005) 1488–1492 1491ampliﬁed by PCR with primers speciﬁc for Tome-1 or the con-
trol actin promoter. DNA fragments containing the CCAAT
box in Tome-1 were detected, whereas no genomic DNA frag-
ment was detected when irrelevant antibody (anti-Flag) or no
antibody was added in place of the anti-NF-YA antibody (Fig.3C). These results indicate that NF-Y associates with the
Tome-1 promoter under physiological conditions. Taken to-
gether, these results indicate that NF-Y may be the major fac-
tor activating the transcription of the Tome-1 promoter, acting
through the CCAAT box.
1492 K. Yoshida / FEBS Letters 579 (2005) 1488–14923.4. Identiﬁcation of cell-cycle-regulated repressor elements in
the Tome-1 promoter
Transcription of S/G2-speciﬁc genes, such as cdc25C, cdc2,
and cyclin A, is mediated by a cell-cycle-regulated repressor ele-
ment, CDE /CHR [6–8]. An alignment of the human andmouse
Tome-1 promoter sequences with the CDE/CHR of these S/G2-
speciﬁc genes showed that the Tome-1 promoter sequence was
perfectly matched with the CHR consensus sequence (Fig. 1B).
Only one base-pair at the center of the putative mouse Tome-1
CDE region was not identical with the consensus sequence,
however, the spacing between these two putative elements in
Tome-1 and their locations within the promoter region were
very similar to that reported for the other S/G2-speciﬁc genes.
These results suggest that the putative CDE/CHR region of
Tome-1 functions as a G1-speciﬁc repressor, as it does in the
other known S/G2-speciﬁc genes.
To conﬁrm the repressor function of these elements, we
performed mutagenesis of CDE and CHR in the Tome-1-pro-
moter–luciferase construct, pGL3-69 (Fig. 3D). The wild-type
and two mutant constructs, M3 (CDE mutant) and M4 (CHR
mutant), were transiently transfected into asynchronously
growing NIH3T3 cells, and no diﬀerences between the wild-
type and the M3 or M4 mutant constructs were detected (data
not shown). Next, the luciferase activity was determined in
cells arrested by serum starvation for 48 h and then released
by serum addition for 10 h (G1) and 26 h (G2/M) (Fig. 3D).
The wild-type construct showed a 6-fold increase of promoter
activity in the G2/M cells relative to that in G1 cells. The CDE
and CHR mutant constructs showed approximately 1.5- and
2.5-fold increase of activity in the G1 cells, respectively. The
CHR mutation decreased the ratio of the promoter activity
measured in G2/M versus G1 cells by 2-fold, whereas the
CDE mutation decreased the ratio by 4-fold (Fig. 3D). These
results indicate that the CDE/CHR element in human Tome-
1 acts as a G1-speciﬁc repressor. The same results were ob-
tained for CDE/CHR element in mouse Tome-1 promoter
(data not shown).
In summary, we have shown that Tome-1 expression is trans-
criptionally regulated in a cell-cycle-dependent manner. This
transcriptional regulation is achieved by the bipartite repressor
element, CDE/CHR. The present study demonstrates that the
cell-cycle-speciﬁc transcriptional regulation is, at least in part,
responsible for the tight regulation of Tome-1 function.
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